Many supplements are available to the general public for a limited time on our SuppleNet page.
VOLUME 59 1998 SUPPLEMENT 8
Articles
3 Introduction. Focus on Panic Disorder:
Antidepressants in Practice.
[PDF]
4 The Road to Recovery in Panic Disorder:
Response, Remission, and Relapse. M. Katherine Shear, M.D.; Duncan Clark, M.D., Ph.D.;
and Ulrika Feske, Ph.D.
[Abstract]
[PDF]
11 The Impact of Comorbidity
on the Treatment of Panic Disorder. Yves Lecrubier, M.D.
[Abstract]
[PDF]
17 The Long-Term Treatment of Panic Disorder. Jonathan R. T. Davidson, M.D.
[Abstract]
[PDF]
24 Antidepressants in Panic Disorder:
Clinical and Preclinical Mechanisms. David J. Nutt, M.D., Ph.D.
[Abstract]
[PDF]
30 Pharmacotherapy of Panic Disorder:
Differential Efficacy From a Clinical Viewpoint. Johan A. den Boer, M.D., Ph.D.
[Abstract]
[PDF]
39 The Side Effect Burden Associated
With Drug Treatment of Panic Disorder. David S. Baldwin, M.R.C.Psych.; and Jon Birtwistle, M.Sc.
[Abstract]
[PDF]
47 Consensus Statement on Panic Disorder
From the International Consensus Group
on Depression and Anxiety. James C. Ballenger, M.D.; Jonathan R. T. Davidson, M.D.;
Yves Lecrubier, M.D.; and David J. Nutt, M.D., Ph.D.
(International Consensus Group on Depression and Anxiety);
and David S. Baldwin, M.R.C.Psych.; Johan A. den Boer, M.D., Ph.D.;
Siegfried Kasper, M.D.; and M. Katherine Shear, M.D.
[Abstract]
[PDF]